Sinovac Biotech Debt to Equity Ratio 2006-2017 | SVA

Current and historical debt to equity ratio values for Sinovac Biotech (SVA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sinovac Biotech debt/equity for the three months ending June 30, 2017 was 0.08.
Sinovac Biotech Annual Debt/Equity Ratio
2017 0.19
2016 0.33
2015 0.18
2014 0.37
2013 0.34
2012 0.27
2011 0.15
2010 0.14
2009 0.21
2008 0.21
2007 0.27
2006 0.34
2005 0.28
Sinovac Biotech Quarterly Debt/Equity Ratio
Q2 2017 0.00
Q4 2016 0.33
Q3 2016 0.30
Q2 2016 0.24
Q1 2016 0.26
Q4 2015 0.18
Q3 2015 0.20
Q2 2015 0.25
Q1 2015 0.24
Q4 2014 0.35
Q3 2014 0.40
Q2 2014 0.37
Q1 2014 0.38
Q4 2013 0.34
Q3 2013 0.36
Q2 2013 0.35
Q1 2013 0.33
Q4 2012 0.27
Q3 2012 0.22
Q2 2012 0.21
Q1 2012 0.18
Q4 2011 0.15
Q3 2011 0.17
Q2 2011 0.15
Q1 2011 0.15
Q4 2010 0.14
Q3 2010 0.07
Q2 2010 0.07
Q1 2010 0.16
Q4 2009 0.21
Q3 2009 0.31
Q2 2009 0.48
Q1 2009 0.21
Q4 2008 0.21
Q3 2008 0.15
Q2 2008 0.19
Q1 2008 0.20
Q4 2007 0.27
Q3 2007 0.24
Q4 2006 0.00
Q4 2005 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.442B $0.174B
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.756B 15.24
Gilead Sciences (GILD) United States $97.005B 10.77
Biogen (BIIB) United States $68.740B 14.57
Celgene (CELG) United States $62.107B 12.40
Illumina (ILMN) United States $52.379B 65.62
Vertex Pharmaceuticals (VRTX) United States $46.134B 104.95
Regeneron Pharmaceuticals (REGN) United States $41.844B 23.53
Alexion Pharmaceuticals (ALXN) United States $27.770B 20.87
BioMarin Pharmaceutical (BMRN) United States $17.830B 0.00
Incyte (INCY) United States $14.515B 487.71
Seattle Genetics (SGEN) United States $12.545B 0.00
Sarepta Therapeutics (SRPT) United States $10.154B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.584B 0.00
Exact Sciences (EXAS) United States $9.205B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
BeiGene (BGNE) Cayman Islands $8.758B 0.00
QIAGEN (QGEN) Netherlands $8.741B 28.58
Bluebird Bio (BLUE) United States $7.685B 0.00
Bio-Techne Corp (TECH) United States $7.513B 50.25
Alkermes (ALKS) Ireland $6.385B 0.00
Galapagos (GLPG) Belgium $5.905B 0.00
Ligand Pharmaceuticals (LGND) United States $5.440B 48.18
Exelixis (EXEL) United States $5.034B 16.40
Ultragenyx Pharmaceutical (RARE) United States $4.330B 0.00
Immunomedics (IMMU) United States $4.209B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.514B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.492B 0.00
Myriad Genetics (MYGN) United States $3.360B 37.60
Emergent Biosolutions (EBS) United States $3.301B 26.30
Array BioPharma (ARRY) United States $3.170B 0.00
Blueprint Medicines (BPMC) United States $3.143B 0.00
Horizon Pharma Public (HZNP) Ireland $3.139B 17.77
Ascendis Pharma (ASND) Denmark $2.824B 0.00
Reata Pharmaceuticals (RETA) United States $2.723B 0.00
China Biologic Products (CBPO) China $2.717B 17.94
Acceleron Pharma (XLRN) United States $2.690B 0.00
MyoKardia (MYOK) United States $2.581B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.580B 0.00
Medicines (MDCO) United States $2.545B 0.00
Halozyme Therapeutics (HALO) United States $2.491B 33.19
Repligen (RGEN) United States $2.489B 83.57
Akcea Therapeutics (AKCA) United States $2.479B 0.00
Genomic Health (GHDX) United States $2.453B 136.84
ACADIA Pharmaceuticals (ACAD) United States $2.389B 0.00
Amicus Therapeutics (FOLD) United States $2.387B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.312B 0.00
REGENXBIO (RGNX) United States $2.312B 36.32
AnaptysBio (ANAB) United States $2.219B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.177B 0.00
Global Blood Therapeutics (GBT) United States $2.155B 0.00
Spark Therapeutics (ONCE) United States $2.148B 0.00
Arena Pharmaceuticals (ARNA) United States $2.126B 0.00
Cambrex (CBM) United States $2.105B 16.88
Denali Therapeutics (DNLI) United States $1.980B 0.00
G1 THERAPEUTICS (GTHX) United States $1.964B 0.00
Mirati Therapeutics (MRTX) United States $1.950B 0.00
Allakos (ALLK) United States $1.897B 0.00
Atara Biotherapeutics (ATRA) United States $1.850B 0.00
Solid Biosciences (SLDB) United States $1.832B 0.00
Puma Biotechnology (PBYI) United States $1.808B 0.00
Myovant Sciences (MYOV) United Kingdom $1.785B 0.00
Clovis Oncology (CLVS) United States $1.710B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.689B 0.00
Insmed (INSM) United States $1.674B 0.00
Rubius Therapeutics (RUBY) United States $1.659B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
Innoviva (INVA) United States $1.599B 10.26
Aimmune Therapeutics (AIMT) United States $1.594B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.563B 0.00
Editas Medicine (EDIT) United States $1.553B 0.00
WAVE Life Sciences (WVE) Singapore $1.545B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.530B 0.00
UniQure (QURE) Netherlands $1.528B 0.00
Audentes Therapeutics (BOLD) United States $1.481B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.480B 0.00
DBV Technologies (DBVT) France $1.378B 0.00
IMMURON LTD (IMRN) Australia $1.371B 0.00
Intellia Therapeutics (NTLA) United States $1.361B 0.00
Lion Biotechnologies (IOVA) United States $1.305B 0.00
Cellectis (CLLS) France $1.213B 0.00
Retrophin (RTRX) United States $1.207B 0.00
Intra-Cellular Therapies (ITCI) United States $1.195B 0.00
NeoGenomics (NEO) United States $1.185B 207.29
Viking Therapeutics (VKTX) United States $1.151B 0.00
AVROBIO (AVRO) United States $1.149B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.135B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.130B 0.00
Apellis Pharmaceuticals (APLS) United States $1.122B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.112B 0.00
Coherus BioSciences (CHRS) United States $1.109B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.105B 0.00
Athenex (ATNX) United States $1.093B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.061B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.050B 2005.00
Dicerna Pharmaceuticals (DRNA) United States $1.038B 0.00
Geron (GERN) United States $1.010B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.944B 0.00
Cara Therapeutics (CARA) United States $0.940B 0.00
Aptinyx (APTX) United States $0.919B 0.00
Revance Therapeutics (RVNC) United States $0.899B 0.00
Acorda Therapeutics (ACOR) United States $0.862B 17.97
Amarin (AMRN) Ireland $0.856B 0.00
CytomX Therapeutics (CTMX) United States $0.847B 0.00
Heska (HSKA) United States $0.825B 70.97
InflaRx (IFRX) Germany $0.805B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.781B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.765B 0.00
Dynavax Technologies (DVAX) United States $0.764B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.756B 0.00
Fate Therapeutics (FATE) United States $0.749B 0.00
Epizyme (EPZM) United States $0.726B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.720B 0.00
UNITY Biotechnology (UBX) $0.712B 0.00
MiMedx (MDXG) United States $0.688B 29.52
Abeona Therapeutics (ABEO) United States $0.671B 0.00
UROGEN PHARMA (URGN) Israel $0.670B 0.00
ObsEva SA (OBSV) Switzerland $0.661B 0.00
Kura Oncology (KURA) United States $0.646B 0.00
Verastem (VSTM) United States $0.644B 0.00
ANI Pharmaceuticals (ANIP) United States $0.642B 12.72
Vericel (VCEL) United States $0.628B 0.00
Mesoblast (MESO) Australia $0.624B 0.00
Arcus Biosciences (RCUS) United States $0.617B 0.00
Scholar Rock Holding (SRRK) United States $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.596B 25.06
Replimune (REPL) United States $0.578B 0.00
Novavax (NVAX) United States $0.562B 0.00
BeyondSpring (BYSI) United States $0.561B 0.00
GTx (GTXI) United States $0.560B 0.00
AC Immune SA (ACIU) Switzerland $0.556B 0.00
Arbutus Biopharma (ABUS) Canada $0.551B 0.00
Zealand Pharma (ZEAL) Denmark $0.551B 0.00
Prothena (PRTA) Ireland $0.543B 0.00
Senesco Technologies (ELOX) United States $0.533B 0.00
Zymeworks (ZYME) Canada $0.531B 0.00
Stemline Therapeutics (STML) United States $0.527B 0.00
Sorrento Therapeutics (SRNE) United States $0.519B 89.00
MediciNova (MNOV) United States $0.511B 0.00
RA PHARMCTL INC (RARX) United States $0.504B 0.00
Five Prime Therapeutics (FPRX) United States $0.502B 0.00
Aduro Biotech (ADRO) United States $0.498B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.491B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.456B 0.00
Inovio Pharmaceuticals (INO) United States $0.448B 0.00
Cytokineticsorporated (CYTK) United States $0.445B 0.00
Merus (MRUS) Netherlands $0.438B 0.00
Kindred Biosciences (KIN) United States $0.438B 0.00
Syros Pharmaceuticals (SYRS) United States $0.430B 0.00
Evelo Biosciences (EVLO) United States $0.428B 0.00
ResTORbio (TORC) United States $0.424B 0.00
Eidos Therapeutics (EIDX) United States $0.407B 0.00
Albireo Pharma (ALBO) United States $0.391B 0.00
Magenta Therapeutics (MGTA) United States $0.383B 0.00
Kezar Life Sciences (KZR) United States $0.383B 0.00
Osiris Therapeutics (OSIR) United States $0.380B 0.00
Kadmon Holdings (KDMN) United States $0.379B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.378B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.376B 0.00
Unum Therapeutics (UMRX) United States $0.366B 0.00
Adverum Biotechnologies (ADVM) United States $0.360B 0.00
Selecta Biosciences (SELB) United States $0.358B 0.00
PDL BioPharma (PDLI) United States $0.356B 5.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.353B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.344B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.333B 0.00
MeiraGTx Holdings (MGTX) United States $0.328B 0.00
Synlogic (SYBX) United States $0.324B 0.00
BioTime (BTX) United States $0.315B 0.00
Celcuity (CELC) United States $0.311B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.306B 0.00
ADMA Biologics Inc (ADMA) United States $0.305B 0.00
Seres Therapeutics (MCRB) United States $0.304B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.294B 0.00
Liquidia Technologies (LQDA) United States $0.291B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.285B 0.00
Mersana Therapeutics (MRSN) United States $0.284B 0.00
Celyad SA (CYAD) Belgium $0.278B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.275B 0.00
TOCAGEN INC (TOCA) United States $0.270B 0.00
Kala Pharmaceuticals (KALA) United States $0.270B 0.00
Menlo Therapeutics (MNLO) United States $0.266B 0.00
NantKwest (NK) United States $0.265B 0.00
Athersys (ATHX) United States $0.258B 0.00
Axovant Sciences (AXON) United Kingdom $0.258B 0.00
MannKind (MNKD) United States $0.257B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.256B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.245B 0.00
Kamada (KMDA) Israel $0.240B 18.59
Agenus (AGEN) United States $0.238B 0.00
Allena Pharmaceuticals (ALNA) United States $0.237B 0.00
Idera Pharmaceuticals (IDRA) United States $0.226B 0.00
ChromaDex (CDXC) United States $0.216B 0.00
Clearside Biomedical (CLSD) United States $0.209B 0.00
Palatin Technologies (PTN) United States $0.208B 8.58
Enzo Biochem (ENZ) United States $0.205B 0.00
Strongbridge Biopharma (SBBP) United States $0.203B 0.00
Compugen (CGEN) Israel $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Constellation Pharmaceuticals (CNST) United States $0.201B 0.00
Cohbar (CWBR) United States $0.200B 0.00
Spero Therapeutics (SPRO) United States $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.193B 0.00
Cue Biopharma (CUE) United States $0.185B 0.00
Monster Digital (INNT) United States $0.176B 0.00
Krystal Biotech (KRYS) United States $0.176B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.176B 0.00
Signal Genetics (MGEN) United States $0.175B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.167B 0.00
Mustang Bio (MBIO) United States $0.166B 0.00
Cerecor (CERC) United States $0.165B 19.67
BioDelivery Sciences (BDSI) United States $0.161B 0.00
Eleven Biotherapeutics (SESN) United States $0.159B 0.00
Pfenex (PFNX) United States $0.159B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.158B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.157B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.154B 0.00
Pluristem Therapeutics (PSTI) Israel $0.151B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.147B 0.00
Intec Pharma (NTEC) Israel $0.146B 0.00
Provention Bio (PRVB) United States $0.141B 0.00
Checkpoint Therapeutics (CKPT) United States $0.141B 0.00
XOMA (XOMA) United States $0.138B 14.55
PSivida (EYPT) United States $0.135B 0.00
Organovo Holdings (ONVO) United States $0.135B 0.00
Tapimmune (TPIV) United States $0.129B 0.00
Motif Bio Plc (MTFB) United States $0.126B 0.00
Trevena (TRVN) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.124B 0.00
VBI Vaccines (VBIV) United States $0.119B 0.00
BioXcel Therapeutics (BTAI) United States $0.118B 0.00
Anavex Life Sciences (AVXL) United States $0.117B 0.00
Aptevo Therapeutics (APVO) United States $0.116B 0.00
Cidara Therapeutics (CDTX) United States $0.115B 0.00
Alcobra (ARCT) United States $0.105B 0.00
ARIDIS PHARMACT (ARDS) United States $0.103B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Leap Therapeutics (LPTX) United States $0.101B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Cel-Sci (CVM) United States $0.097B 0.00
XBiotech (XBIT) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.096B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Proteostasis Therapeutics (PTI) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
Ophthotech (OPHT) United States $0.089B 0.58
Protalix BioTherapeutics (PLX) Israel $0.089B 0.00
NewLink Genetics (NLNK) United States $0.088B 0.00
Fortress Biotech (FBIO) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 0.00
Prima BioMed (IMMP) Australia $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Sophiris Bio (SPHS) United States $0.080B 0.00
VolitionRX (VNRX) Singapore $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 0.00
Asterias Biotherapeutics (AST) United States $0.078B 0.00
Chiasma (CHMA) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
OncoSec Medical (ONCS) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.073B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.073B 0.00
Celldex Therapeutics (CLDX) United States $0.070B 0.00
Novelion Therapeutics (NVLN) Canada $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.067B 0.00
TRACON Pharmaceuticals (TCON) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
Caladrius Biosciences (CLBS) United States $0.063B 0.00
CorMedix Inc (CRMD) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.056B 0.00
VIVUS (VVUS) United States $0.056B 0.00
Curis (CRIS) United States $0.054B 0.00
Celsion (CLSN) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
Aileron Therapeutics (ALRN) United States $0.047B 0.00
Eyenovia (EYEN) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Advaxis (ADXS) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
GENPREX INC (GNPX) United States $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.036B 0.00
CytRx (CYTR) United States $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Gemphire Therapeutics (GEMP) United States $0.033B 0.00
Vical (VICL) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.029B 58.00
VTv Therapeutics (VTVT) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Arsanis (ASNS) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Edge Therapeutics (EDGE) United States $0.023B 0.00
RestorGenex (DFFN) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
Fibrocell Science Inc (FCSC) United States $0.021B 0.00
Therapix Biosciences (TRPX) Israel $0.020B 7.43
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Neuralstem (CUR) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
AmpliPhi Biosciences (APHB) United States $0.015B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.006B 0.00
Oragenics (OGEN) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00